JCO-ovid
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1041
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ONCOLOGY GOLD STANDARD

Guidelines for treatment of recurrent or metastatic head and neck cancer

Parikh P, Patil V, Agarwal J P, Chaturvedi P, Vaidya A, Rathod S, Noronha V, Joshi A, Jamshed A, Bhattacharya G S, Gupta S, Desai C, Advani S H, Pai P, Laskar S, Ramesh A, Mohapatra P N, Vaid A K, Deshpande M, Ranade A A, Vora A, Baral R, Hussain M A, Rajan B, Dcruz A K, Prabhash K

Year : 2014| Volume: 51| Issue : 2 | Page no: 89-94

   This article has been cited by
 
1 Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer
Amit Joshi,Vijay Patil,Vanita Noronha,Sachin Dhumal,Nikhil Pande,Arun Chandrasekharan,Siddharth Turkar,Hollis DSouza,Sameer Shrirangwar,Abhishek Mahajan,Supreeta Arya,Shashikant Juvekar,Atanu BhattaCharjee,Kumar Prabhash
Oral Oncology. 2017; 75: 54
[Pubmed]  [Google Scholar] [DOI]
2 The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
Xiaodong Feng,Qingqiong Luo,Han Zhang,Han Wang,Wantao Chen,Guangxun Meng,Fuxiang Chen
Journal of Experimental & Clinical Cancer Research. 2017; 36(1)
[Pubmed]  [Google Scholar] [DOI]
3 Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma
Aarti Mohan,Shridhar Narayanan,Gopalan Balasubramanian,Swaminathan Sethuraman,Uma Maheswari Krishnan
European Journal of Pharmaceutics and Biopharmaceutics. 2016; 99: 73
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow